NCT07500298
- Conditions
- Bevacizimab, Colonic Diseases, Colorectal Neoplasms, +15 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Explore clinical trials studying First Line Treatment. Study availability and eligibility vary by location and protocol.
NCT07500298
NCT06981325
NCT07725705
Not specified
NCT06374160
NCT01980212
NCT02055508